Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Sep. 30, 2023
Current assets
Cash and equivalents	$ 2,076	$ 8,051
Receivables, less allowances of $100 and $112, respectively	2,759	2,518
Inventories	2,432	2,006
Other current assets	1,399	1,244
Total current assets	8,666	13,819
Property, plant and equipment, net	2,701	2,363
Other assets
Goodwill	17,983	14,480
Other intangible assets	11,270	6,263
Copeland note receivable and equity investment	3,253	3,255
Other	2,640	2,566
Total other assets	35,146	26,564
Total assets	46,513	42,746
Current liabilities
Short-term borrowings and current maturities of long-term debt	3,227	547
Accounts payable	1,234	1,275
Accrued expenses	3,304	3,210
Total current liabilities	7,765	5,032
Long-term debt	7,632	7,610
Other liabilities	4,561	3,506
Equity
Common stock, $0.50 par value; authorized, 1,200.0 shares; issued, 953.4 shares; outstanding, 572.0 shares and 571.7 shares, respectively	477	477
Additional paid-in-capital	140	62
Retained earnings	39,910	40,070
Accumulated other comprehensive income (loss)	(1,090)	(1,253)
Cost of common stock in treasury, 381.4 shares and 381.7 shares, respectively	(18,763)	(18,667)
Common stockholders’ equity	20,674	20,689
Noncontrolling interests in subsidiaries	5,881	5,909
Total equity	26,555	26,598
Total liabilities and equity	$ 46,513	$ 42,746